Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast
Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.
Related Resources
Guides/Reports
The UDI Impacts on Recall Management Work Group, a part of AHRMM's Learning UDI Community (LUC), has released their recommended practices reports…
White Papers
Consider how direct sourcing can enable access to PPE and the leading practices of
building supply chain diversity and resiliency for the future in…
Guides/Reports
Though the health care industry is continuing to tackle the COVID-19 pandemic, many industry leaders are also looking to build a more resilient sup
Guides/Reports
As health care emerges from the COVID-19 pandemic, supply chain resiliency is a priority.
Podcasts
Learn the best practices of setting PAR levels and what you need to know to ensure you have the proper stock.
White Papers
Healthcare expenses continue to rise and yet hospitals are realizing consistently shrinking margins.